Bioretec acquired Austria-based BRI.Tech, developer of a patented novel biocompatible and bioresorbable metal composition. Human clinical study of products made from this composition is underway. In development and pre-clinical phases, the composition was shown to have superior material properties over first-generation bioresorbable metal compositions.
Bioretec, located in Finland, markets the Activa line of poly-L-lactide-co-glycolide-based bioresorbable and bioactive pins, nails and screws for orthopedic and trauma applications. The company is developing projects that include fiber-reinforced biopolymer composite materials, and this transaction will add another material option to its portfolio.
Source: Bioretec Ltd.
Bioretec acquired Austria-based BRI.Tech, developer of a patented novel biocompatible and bioresorbable metal composition. Human clinical study of products made from this composition is underway. In development and pre-clinical phases, the composition was shown to have superior material properties over first-generation...
Bioretec acquired Austria-based BRI.Tech, developer of a patented novel biocompatible and bioresorbable metal composition. Human clinical study of products made from this composition is underway. In development and pre-clinical phases, the composition was shown to have superior material properties over first-generation bioresorbable metal compositions.
Bioretec, located in Finland, markets the Activa line of poly-L-lactide-co-glycolide-based bioresorbable and bioactive pins, nails and screws for orthopedic and trauma applications. The company is developing projects that include fiber-reinforced biopolymer composite materials, and this transaction will add another material option to its portfolio.
Source: Bioretec Ltd.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
